New treatment ideas for glomerular kidney disease from podocyte cell mechanics
Revealing New Therapeutic Opportunities for Kidney Glomerular Diseases by Elucidating the Mechanobiological Functions of Novel Cytoskeletal Structures in Podocytes
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-11163406
This project looks at how tiny structures in kidney filtering cells (podocytes) keep the filter working, with the goal of finding new treatments for people with glomerular diseases like Alport syndrome.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11163406 on ClinicalTrials.gov |
What this research studies
This research focuses on podocytes, specialized cells that help the kidney filter blood, and the tiny cytoskeletal structures that keep their finger-like 'foot processes' shaped and attached. Scientists will use lab models and molecular techniques to see how these structures fail in glomerular diseases such as Alport syndrome and how that leads to protein leaking into the urine. They will test proof-of-concept approaches aimed at stabilizing podocyte shape and adhesion to the glomerular basement membrane. The goal is to turn those lab findings into targets that could be developed into treatments to protect kidney function.
Who could benefit from this research
Good fit: People with glomerular diseases—such as Alport syndrome—or those with proteinuria or early-stage podocyte injury would be most relevant to benefit from eventual therapies developed from this work.
Not a fit: Patients whose kidney problems are due to non-glomerular causes, or those already on dialysis or after kidney transplant for end-stage disease, may not directly benefit from these early mechanistic findings.
Why it matters
Potential benefit: If successful, this work could identify targets for drugs that prevent podocyte damage, reduce proteinuria, and slow progression to kidney failure.
How similar studies have performed: Prior research has described podocyte biology and identified some potential targets, but translating these findings into effective therapies has been limited, so this project builds on existing knowledge while testing new therapeutic ideas.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MINER, JEFFREY H — WASHINGTON UNIVERSITY
- Study coordinator: MINER, JEFFREY H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alport syndrome, Alport syndrome (AS, ATS)